There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated Glycosaminoglycan in
horses. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended
for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. Caution:
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Each 5 mL contains 500 mg Polysulfated
Glycosaminoglycan. Brief Summary Indications: For the intramuscular treatment of non-infectious degenerative and/or traumatic
joint dysfunction and associated lameness of the carpal and hock joints in horses.
See Product Package Insert at www.adequan.com for Full Prescribing Information
Adequan
®
is a registered trademark of Luitpold Pharmaceuticals, Inc.
©2015 Luitpold Pharmaceuticals, Inc., Animal Health Division Shirley, NY 11967. AHD110 Iss. 3/2015
Available through your veterinarian
The Winning Formula
for Champions
The only FDA-approved PSGAG on the
market for equine intramuscular use
proven to:
• STOP the destructive disease cycle
• REVERSE degenerative joint disease
• IMPROVE joint function
For more information on equine joint
health and treatment with Adequan
®
i.m. (polysulfated glycosaminoglycan),
please visit www.adequan.com
